Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues

被引：42

作者：

Torres, J

Navarro, S

Roglá, I

Ripoll, F

Lluch, A

García-Conde, J

Llombart-Bosch, A

Cervera, J

Pulido, R

机构：

[1] Inst Invest Citol, Valencia 46010, Spain

[2] Univ Valencia, Dept Patol, Valencia, Spain

[3] Univ Valencia, Hosp Clin Valencia, Serv Oncol & Hematol, Valencia, Spain

来源：

EUROPEAN JOURNAL OF CANCER | 2001年 / 37卷 / 01期

关键词：

PTEN; tumour suppressor; cancer; protein phosphatases;

D O I：

10.1016/S0959-8049(00)00366-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PTEN, a tumour suppressor gene located at chromosome 10q23 and commonly mutated or deleted in a variety of tumours, encodes a dual-specific/phosphatidylinositol-3,4,5-triphosphate (PIP3) phosphatase. We report the generation of an anti-PTEN monoclonal antibody (MAb) that recognises an epitope at the C-terminus of PTEN, and describe the heterogeneous lack of expression of the PTEN protein in human tumour tissues, as demonstrated by immunohistochemical methods. Our anti-PTEN MAb provides a useful tool for the study of PTEN protein expression in tumour samples, in the search for tumour prognostic molecular markers. (C) 2001 Elsevier Science Ltd. All rights reserved.

引用

收藏

页码：114 / 121

页数：8

相关论文

共 47 条

[31] Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease [J].

Nelen, MR ;

vanStaveren, WCG ;

Peeters, EAJ ;

BenHassel, M ;

Gorlin, RJ ;

Hamm, H ;

Lindboe, CF ;

Fryns, JP ;

Sijmons, RH ;

Woods, DG ;

Mariman, ECM ;

Padberg, GW ;

Kremer, H .

HUMAN MOLECULAR GENETICS, 1997, 6 (08) :1383-1387

[32] Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast [J].

Perren, A ;

Weng, LP ;

Boag, AH ;

Ziebold, U ;

Thakore, K ;

Dahia, PLM ;

Komminoth, P ;

Lees, JA ;

Mulligan, LM ;

Mutter, GL ;

Eng, C .

AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1253-1260

[33] Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems [J].

Podsypanina, K ;

Ellenson, LH ;

Nemes, A ;

Gu, JG ;

Tamura, M ;

Yamada, KM ;

Cordon-Cardo, C ;

Catoretti, G ;

Fisher, PE ;

Parsons, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) :1563-1568

[34] PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif [J].

Pulido, R ;

Zúñiga, A ;

Ullrich, A .

EMBO JOURNAL, 1998, 17 (24) :7337-7350

[35]

Rasheed BKA, 1997, CANCER RES, V57, P4187

[36]

Rhei E, 1997, CANCER RES, V57, P3657

[37]

Sano T, 1999, CANCER RES, V59, P1820

[38] Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression [J].

Somerville, RPT ;

Shoshan, Y ;

Eng, C ;

Barnett, G ;

Miller, D ;

Cowell, JK .

ONCOGENE, 1998, 17 (13) :1755-1757

[39] Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN [J].

Stambolic, V ;

Suzuki, A ;

de la Pompa, JL ;

Brothers, GM ;

Mirtsos, C ;

Sasaki, T ;

Ruland, J ;

Penninger, JM ;

Siderovski, DP ;

Mak, TW .

CELL, 1998, 95 (01) :29-39

[40] Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers [J].

Steck, PA ;

Pershouse, MA ;

Jasser, SA ;

Yung, WKA ;

Lin, H ;

Ligon, AH ;

Langford, LA ;

Baumgard, ML ;

Hattier, T ;

Davis, T ;

Frye, C ;

Hu, R ;

Swedlund, B ;

Teng, DHF ;

Tavtigian, SV .

NATURE GENETICS, 1997, 15 (04) :356-362

← 1 2 3 4 5 →